Fluoxetine Opens Window to Improve Motor Recovery After Stroke
Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The FLOW trial is a randomized placebo-controlled trial analyzing the effect of coupling an
anti-depressant, fluoxetine (Prozac), and exercise to improve motor recovery following a
stroke.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborators:
Applied Health Research Centre Brain Canada Dalhousie University Heart and Stroke Foundation Canadian Partnership for Stroke Recovery Memorial University of Newfoundland Parkwood Hospital, London, Ontario Riverview Health Centre Foundation Sunnybrook Health Sciences Centre University of British Columbia University of Calgary University of Waterloo